newdrugapprovals.org
FDA approves new drug Doptelet (avatrombopag) for patients with chronic liver disease who have low blood platelets and are undergoing a medical procedure
Avatrombopag FDA approves new drug for patients with chronic liver disease who have low blood platelets and are undergoing a medical procedure The U.S. Food and Drug Administration today approved D…